AI brief of an SEC Form 8-K · Versant Media Group (VSNT)

Versant completes Comcast spin-off and begins trading on Nasdaq as VSNT

Neutral Impact 4 of 5 shareholder Written later

Versant Media Group completed its separation from Comcast on January 2, 2026, with Comcast shareholders receiving Versant shares through a distribution. Versant now operates as an independent, publicly traded company, with Comcast retaining no ownership interest, and its shares began trading on Nasdaq under VSNT on January 5, 2026. The filing also sets out agreements with Comcast covering separation, taxes, transition services and employee matters that shape the companies' ongoing relationship.

Key points

  • Distribution ratio: one Versant share for every 25 Comcast shares held on the December 16, 2025 record date
  • Distribution completed after the close of trading on January 2, 2026; Versant began trading on Nasdaq as VSNT on January 5, 2026
  • Transition services from Comcast may run for up to two years following the distribution
  • Separation and Distribution Agreement provides for uncapped cross-indemnities between Versant and Comcast

The filing

CompanyVersant Media Group (VSNT)
Form8-K, current report
Filed with the SECJan 5, 2026, 8:05 AM ET
Accession number0000950103-26-000080

Items reported: 1.01 Material Definitive Agreement2.01 Acquisition or Disposition Completed2.03 New Direct Financial Obligation5.01 Change in Control5.02 Director / Officer Change5.03 Bylaw / Charter Amendment8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.